Clinical Trials Logo

Thoracic Surgery, Video-Assisted clinical trials

View clinical trials related to Thoracic Surgery, Video-Assisted.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05907525 Recruiting - Clinical trials for One-Lung Ventilation

Effect of Sevoflurane and Remimazolam on Arterial Oxygenation During One-lung Ventilation

Start date: June 29, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to compare the effect of sevoflurane and remimazolam on arterial oxygenation during one lung ventilation in patients undergoing video-assisted thoracoscopic surgery.

NCT ID: NCT05834569 Recruiting - Delirium Clinical Trials

Impact of Maxigesic on Delirium After Minimally Invasive Lung Surgery in Elderly Patients

Start date: June 15, 2023
Phase: Phase 4
Study type: Interventional

The primary aim of this interventional study is to investigate the impact of perioperative administration of Maxigesic (combination of acetaminophen and ibuprofen) on delirium after minimally invasive lung surgery in elderly patients. The Maxigesic group receives a total of 5 doses of Maxigesic (20mg/kg, maximum dose per serving: 1g) every 6 h from immediately after anesthesia induction. The control group receives the same volume of normal saline. Researchers compare the incidence and severity of postoperative delirium for 5 days after surgery.

NCT ID: NCT05600569 Recruiting - Lung Neoplasm Clinical Trials

Registry of the Spanish Society of Thoracic Surgery

ReSECT
Start date: January 1, 2023
Phase:
Study type: Observational [Patient Registry]

ReSECT is a project promoted by the Spanish Society of Thoracic Surgery with the aim not only to become an indefinite, dynamic and inclusive registry, but also to establish a common structural framework for the development of future multicentre projects in the field of thoracic surgery in Spain. The goal of this nationwide prospective observational registry is: - To develop and validate forecasting tools based on powerful computational methods with the goal of assisting in decision-making and improving quality of care. - To evaluate the progressive implementation of certain surgical techniques that are on the rise, new technologies and future health programs. - To be aware of our results as specialty and professionals and to serve as a permanent benchmarking instrument in thoracic surgery. The first part of ReSECT, based on a personal registry design, will contemplate any thoracic surgical procedure performed by thoracic surgeons and residents in thoracic surgery in our country. Additionally, the Spanish thoracic surgery departments that voluntarily accept to collectively participate will contribute to specific surgical processes focused on certain procedures with specific objectives to be progressively implemented. The first and only surgical process implemented since the start of the ReSECT project will focus on patients to undergo anatomical lung resection with special interest in those cases whose reason for intervention was lung cancer. The main questions to answer in case of that first surgical process include: - What is the performance of current predictive models for perioperative and oncological outcomes in our country? - How could we modify previous predictive models to improve their performance? - What is the implementation of current guideline recommendations in our country and across institutions? - What is the potential impact of deviations from current recommendations? - What is my performance compared to the rest of the thoracic surgical departments in my country in terms of perioperative and oncological outcomes? ReSECT does not consider prespecified comparison groups of patients.

NCT ID: NCT05255536 Recruiting - Pain, Postoperative Clinical Trials

Effect of Different Local Anesthetic Volumes of Serratus Anterior Plan Block After Video-Assisted Thoracoscopic Surgery

Start date: February 15, 2022
Phase: N/A
Study type: Interventional

Video-assisted thoracic surgery (VATS) has become a common procedure in thoracic surgery. Severe postoperative pain may be encountered in patients undergoing VATS. Analgesic methods such as thoracic paravertebral block (TPVB), intercostal block, serratus anterior plane block (SAPB), and erector spinae plane block (ESPB) are widely used for VATS. Among these methods, ultrasound (US) guided TPVB is the most preferred method. In recent years, the frequency of application of plane blocks as a component of multimodal analgesia has been increased. ESPB and SAPB are some of them. In addition, SAPB application is increasing in patients who underwent thoracotomy and VATS. There is no consensus on the dose of analgesia in these studies. There are studies on volumes between 10 ml and 40 ml in the literature. In this study, it was aimed to compare the volumes of 20 ml and 30 ml containing local anesthetic at the same concentration (0.25% bupivacaine) of SAPB block to be performed with USG in patients who underwent VATS.

NCT ID: NCT04062045 Recruiting - Clinical trials for Thoracic Surgery, Video-Assisted

Efficacy of Continous Regional Anesthesia Using m. Erector Spinae Catheter After VATS Procedures

Start date: October 14, 2019
Phase: N/A
Study type: Interventional

Investigators will analyze the efficacy of continuous regional anesthesia through a catheter under erector spinae muscle in a prospective, randomized, double blind, placebo-controlled study. Investigators will include 50 adults, predicted for elective lung surgery with video-assisted thoracic surgery (VATS) technique. Patients will be randomly assigned to group A or B. Investigators will insert a catheter under the erector spinae muscle (ESC) at the T4 level of the operated side under ultrasound guidance. All patients will receive an initial bolus of 20ml levobupivacaine 0,5% through the catheter. Group A will receive a continuous infusion 5ml/h of ropivacaine 0,2% and intermittent boluses of the same local anesthetic 15ml/4h through the ESC. Group B will receive a continuous infusion of 0,9% saline in the same doses. All patients will have a PCA pump with piritramide 1mg/ml to cover the pain. All patients will receive regular doses of paracetamol and metamizole as part of multimodal analgesia. Investigators will compare pain, assessed with the VAS scale in resting and coughing and piritramide usage in both groups. Investigators will compare the incentive spirometry results at 24 and 48 hours postoperatively and observe for possible late complications.

NCT ID: NCT03666299 Recruiting - Chronic Pain Clinical Trials

Lidocaine Infusion for Postthoracotomy Pain Syndrome

LIPPS
Start date: November 6, 2018
Phase: N/A
Study type: Interventional

This study seeks to investigate lidocaine infusion to reduce postthoractomy pain syndrome after thoracic Surgery

NCT ID: NCT03230019 Recruiting - Clinical trials for Thoracic Surgery, Video-Assisted

Two-Lumen Catheterization For Lung Wedge Resection

Start date: August 25, 2017
Phase: N/A
Study type: Interventional

This study evaluates the viability and safety of two-lumen catheterization versus chest tube placement in patients with lung wedge resection. Half of participants will receive routine chest tube placement, while the other half will receive a two-lumen central venous catheterization along the midclavicular line, second intercostal space for remedial gas-remove.

NCT ID: NCT02959515 Recruiting - Clinical trials for One-Lung Ventilation

The Effects of Different Types of Non-ventilated Lung Management on DO2 During OLV in the Supine Position

OLVinFACHIR
Start date: October 2016
Phase: N/A
Study type: Interventional

The aim of this study is the comparison of oxygen delivery during OLV+capnothorax and OLV+capnothorax and CPAP.

NCT ID: NCT00425022 Recruiting - Clinical trials for Carcinoma, Non-Small-Cell Lung

VATS Lobectomy for Clinical Stage IB or II Lung Cancer

Start date: January 2007
Phase: Phase 2
Study type: Interventional

To examine the feasibility of VATS lobectomy for clinical stage IB or II non-small cell lung cancer. Success is defined as VATS lobectomy without conversion. If success rate over 90%, VATS lobectomy is considered as feasible procedures for clinical stage IB or II non-small cell lung cancer